ClinicalTrials.gov
public full text
Public Domain
Assays for and Reversal of New Anticoagulants
New anticoagulants are being introduced to replace warfarin. These drugs do not require monitoring and are safer. There is currently no recommended way to reverse these drugs rapidly in the event of undue bleeding or need for emergency surgery. This is a lab study to look at ways to reverse the drugs rapidly
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Patients on Antithrombotics for Colonoscopy#832171
- Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist#1308429
- Microvisk Continuous Blood Donation Study#1246902
- Anticoagulation in Post MI LV Thrombus Trial in Nepal#1138409
- LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke#1094959
Record · ID 1295793
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive